Literature DB >> 7507794

Alpha-fetoprotein-producing gastric carcinoma with enteroblastic differentiation.

H Matsunou1, F Konishi, R E Jalal, N Yamamichi, A Mukawa.   

Abstract

BACKGROUND: Alpha-fetoprotein (AFP) is a useful tumor marker for hepatoma and yolk sac tumor. Recently, elevations of serum AFP were reported in patients with other malignancies, especially gastric cancers. Two distinct tumor morphologies, hepatoid and clear cell, have been correlated with AFP production.
METHODS: Two patients with AFP-producing gastric carcinoma were evaluated with immunohistochemical, ultrastructural, and biochemical studies.
RESULTS: In Patient 1, the primary and metastatic carcinomas consisted homogeneously of tubulopapillary carcinoma with clear cytoplasm. In Patient 2, the cancer was composed of three different areas: tubulopapillary carcinoma with clear cytoplasm, tumor cartilage, and so-called hepatoid carcinoma. The morphologic characteristics of tubulopapillary carcinoma with clear cytoplasm were similar to those of the developing gut epithelium at the stage of 2-4 months' gestation. The elution patterns of the serum AFP on lectin-affinity sepharose column study also suggested a correlation with fetal gut differentiation.
CONCLUSIONS: AFP-producing clear cell gastric carcinomas are differentiated into fetal intestine. One patient also had hepatocytic and cartilaginous differentiation, indicative of a blastomatous characteristic of the tumor. These tumors arose in association with intestinal metaplasia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507794     DOI: 10.1002/1097-0142(19940201)73:3<534::aid-cncr2820730307>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

Review 1.  Emerging actions of the nuclear receptor LRH-1 in the gut.

Authors:  Pablo J Fernandez-Marcos; Johan Auwerx; Kristina Schoonjans
Journal:  Biochim Biophys Acta       Date:  2010-12-29

Review 2.  Resection of liver metastasis from alpha-fetoprotein-producing early gastric cancer: report of a case.

Authors:  T Tsurumachi; H Yamamoto; K Watanabe; I Honda; S Watanabe; S Yamada; K Jingu; D Satomi; M Fujita
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

3.  Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.

Authors:  Takashi Murakami; Takashi Yao; Hiroyuki Mitomi; Takashi Morimoto; Hiroya Ueyama; Kenshi Matsumoto; Tsuyoshi Saito; Taro Osada; Akihito Nagahara; Sumio Watanabe
Journal:  Gastric Cancer       Date:  2015-04-18       Impact factor: 7.370

4.  Double cancer of the stomach, one AFP-producing tumor.

Authors:  T Hyodo; R Kawamoto
Journal:  J Gastroenterol       Date:  1996-12       Impact factor: 7.527

5.  Clinical and prognostic characteristics of papillary clear carcinoma of stomach.

Authors:  K Uefuji; T Ichikura; S Tamakuma
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

6.  Elevated serum alpha-fetoprotein in a patient with undifferentiated carcinoma of the gall bladder.

Authors:  W K Ng; W F Ng
Journal:  J Clin Pathol       Date:  1995-11       Impact factor: 3.411

7.  Alpha-fetoprotein in canine multicentric lymphoma.

Authors:  R Lechowski; D Jagielski; M Hoffmann-Jagielska; M Zmudzka; A Winnicka
Journal:  Vet Res Commun       Date:  2002-06       Impact factor: 2.459

8.  Hep Par 1 expression in carcinoma of the cervix: implications for diagnosis and prognosis.

Authors:  T P Thamboo; A Wee
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

9.  Genetic evolution of alpha fetoprotein producing gastric cancer.

Authors:  H Fujii; K Ichikawa; T Takagaki; Y Nakanishi; M Ikegami; S Hirose; T Shimoda
Journal:  J Clin Pathol       Date:  2003-12       Impact factor: 3.411

10.  Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets.

Authors:  Jun Lu; Yongfeng Ding; Yanyan Chen; Junjie Jiang; Yiran Chen; Yingying Huang; Mengjie Wu; Chengzhi Li; Mei Kong; Wenyi Zhao; Haohao Wang; Jing Zhang; Zhongqi Li; Yimin Lu; Xiongfei Yu; Ketao Jin; Donghui Zhou; Tianhua Zhou; Fei Teng; Haibin Zhang; Zhan Zhou; Haiyong Wang; Lisong Teng
Journal:  Nat Commun       Date:  2021-06-24       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.